Last reviewed · How we verify
NCT07154407: AI-assisted
AI-assisted Masticatory Muscle Training in Patients With Schizophrenia
NA trial testing AI-assisted Mastisting Training App in Schizophrenia Disorder in 100 participants. Not yet recruiting.
30 September 2027
Quick facts
| Lead sponsor | Kaohsiung Medical University Chung-Ho Memorial Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 100 |
| Start date | 11 September 2025 |
| Primary completion | 30 September 2027 |
| Estimated completion | 31 December 2027 |
Drugs / interventions tested
- AI-assisted Mastisting Training App
Conditions studied
- Schizophrenia Disorder — all drugs for Schizophrenia Disorder →
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Who can join
20 and older, any sex, with Schizophrenia Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Dysphagia seems to be quite common and potentially severe in schizophrenia, which may lead to acute asphyxia or pneumonia. Dysphagia in schizophrenia could be associated with drug-induced Parkinsonism, dystonia, tardive dyskinesia, dry mouth, excessive saliva, and other complications. Inadequate oral hygiene may lead to the accumulation of plaque, which can cause oral diseases and consequently result in tooth loss. This could be one of the significant factors affecting impaired masticating and swallowing abilities. An experimental study with random assignment will be adopted. The participants from 2 hospitals will be assigned to two groups: experimental group (n=50), and control group (n=50). The experimental group will receive 'AI-assisted Masticatory Muscle Training' sessions, each lasting 20 minutes, before each of their three daily meals. The plaque index, Winkle tongue-coating index, dry mouth, repetitive saliva swallowing, saliva flow rate, biting force, tongue pressure, oral frailty, RSST, DDK, and oral care behaviors were assessed at baseline, as well as during the 3-month follow-ups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07154407
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Schizophrenia Disorder
Currently open trials in the same condition.
- NCT07434479 — A Virtual Reality Mindfulness Application for Aggression in Schizophrenia · NA · recruiting
- NCT07177261 — Inter-Brain Synchrony in Schizophrenia · NA · recruiting
- NCT07309172 — KetoBrain: Brain Energy Metabolism in Schizophrenia · recruiting
Other Kaohsiung Medical University Chung-Ho Memorial Hospital trials
Trials by the same sponsor.
- NCT07342426 — High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis · Phase 4 · recruiting
- NCT07346469 — Exploring the Effects of Magnesium Ions on Peripheral Neuropathy, Serum Magnesium Ion Concentration,Sleep Quality, and Q · NA · not yet recruiting
- NCT07154628 — Effect of Topical Lidocaine Spraying on the Vocal Cords Before Intubation During Robotic Surgery: a Randomized Controlle · Phase 4 · not yet recruiting
- NCT07126444 — Effects of an Exercise Snack Intervention on Employee Health and Work Performance · not yet recruiting
- NCT06863064 — Brain Tumor Surgery and Postoperative Delirium · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07154407 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kaohsiung Medical University Chung-Ho Memorial Hospital
- Last refreshed: 4 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07154407.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing